发明名称 |
PHARMACEUTICAL FORMULATION |
摘要 |
PURPOSE: A pharmaceutical formulation containing atorvastatin and irbesartan is provided to effectively prevent and treat hypertension, hyperlipidemia and their complication. CONSTITUTION: A pharmaceutical formulation of which release is controlled comprises a immediate release compartment containing atorvastatin as a pharmacologically active ingredient, its pharmaceutically acceptable salt, or its isomer, and a sustained release compartment containing irbesartan as pharmacologically active ingredient, its pharmaceutically acceptable salt or its isomer. The sustained release compartment contains osmosis controlling agent and is coated with semi-permeable coating substrate. The pharmaceutical formulation is used in the form of matrix.
|
申请公布号 |
KR20090114328(A) |
申请公布日期 |
2009.11.03 |
申请号 |
KR20090037380 |
申请日期 |
2009.04.29 |
申请人 |
HANALL PHARMACEUTICAL COMPANY LTD. |
发明人 |
KIM, SUNG WUK;JUN, SUNG SOO;LEE, AH RAM;CHOI, JIN WON |
分类号 |
A61K9/22;A61K9/52;A61K47/38;A61P9/12 |
主分类号 |
A61K9/22 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|